Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MICHAEL R GENIN

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1770950107
CMS profile
10528777
Location
SPRINGFIELD, IL

General Payments · PY2021–2024

$585.56

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$278.39

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $278.39 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $131.90 6
ABBVIE INC. $66.72 4
Tandem Diabetes Care, Inc. $26.95 2
Abbott Laboratories $20.05 1
Xeris Pharmaceuticals, Inc. $18.85 1
CALLIDITAS THERAPEUTICS US INC. $13.92 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $81.14 7
PY2022 $12.50 1
PY2023 $213.53 9
PY2024 $278.39 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $20.05 02/20/2024 Food and Beverage Undisputed 01/23/2026 1125266940 CMS
ABBVIE INC. $19.16 05/17/2024 Food and Beverage Undisputed 01/23/2026 1107161759 CMS
ABBVIE INC. $13.15 07/29/2024 Food and Beverage Undisputed 01/23/2026 1107161761 CMS
ABBVIE INC. $17.74 09/11/2024 Food and Beverage Undisputed 01/23/2026 1107161763 CMS
ABBVIE INC. $16.67 11/07/2024 Food and Beverage Undisputed 01/23/2026 1107161765 CMS
CALLIDITAS THERAPEUTICS US INC. $13.92 11/19/2024 Food and Beverage Undisputed 01/23/2026 1141527570 CMS
Novo Nordisk Inc $21.13 05/15/2024 Food and Beverage Undisputed 01/23/2026 1100417031 CMS
Novo Nordisk Inc $17.60 06/17/2024 Food and Beverage Undisputed 01/23/2026 1100515717 CMS
Novo Nordisk Inc $23.48 08/12/2024 Food and Beverage Undisputed 01/23/2026 1100487735 CMS
Novo Nordisk Inc $25.52 09/16/2024 Food and Beverage Undisputed 01/23/2026 1100331090 CMS
Novo Nordisk Inc $13.31 11/05/2024 Food and Beverage Undisputed 01/23/2026 1100475295 CMS
Novo Nordisk Inc $30.86 11/15/2024 Food and Beverage Undisputed 01/23/2026 1100571510 CMS
Tandem Diabetes Care, Inc. $8.60 03/13/2024 Food and Beverage Undisputed 01/23/2026 1138739295 CMS
Tandem Diabetes Care, Inc. $18.35 05/25/2024 Food and Beverage Undisputed 01/23/2026 1138739349 CMS
Xeris Pharmaceuticals, Inc. $18.85 05/06/2024 Food and Beverage Undisputed 01/23/2026 1144635252 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.